<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id>
<journal-id journal-id-type="hwp">jbc</journal-id>
<journal-id journal-id-type="pmc">jbc</journal-id>
<journal-id journal-id-type="publisher-id">JBC</journal-id>
<journal-title-group>
<journal-title>The Journal of Biological Chemistry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9258</issn>
<issn pub-type="epub">1083-351X</issn>
<publisher>
<publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name>
<publisher-loc>11200 Rockville Pike, Suite 302, Rockville, MD 20852-3110, U.S.A.</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27129268</article-id>
<article-id pub-id-type="pmc">4933227</article-id>
<article-id pub-id-type="publisher-id">M116.728824</article-id>
<article-id pub-id-type="doi">10.1074/jbc.M116.728824</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Bases of Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Functional Study of Mutations in K<sup>+</sup>-dependent Na<sup>+</sup>-Ca<sup>2+</sup> Exchangers Associated with Amelogenesis Imperfecta and Non-syndromic Oculocutaneous Albinism<xref ref-type="fn" rid="FN1">*</xref></article-title>
<alt-title alt-title-type="short">Functional Analysis of Human SLC24A4 and SLC24A5 Mutations</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Jalloul</surname>
<given-names>Ali H.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogasevskaia</surname>
<given-names>Tatiana P.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szerencsei</surname>
<given-names>Robert T.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schnetkamp</surname>
<given-names>Paul P. M.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">From the Department of Physiology and Pharmacology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>1</label> To whom correspondence should be addressed: <addr-line>3230 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada.</addr-line> Tel.: <phone>403-220-6862</phone>; E-mail: <email>pschnetk@ucalgary.ca</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>17</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>4</month>
<year>2016</year>
</pub-date>
<volume>291</volume>
<issue>25</issue>
<fpage>13113</fpage>
<lpage>13123</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>The American Society for Biochemistry and Molecular Biology, Inc.</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="zbc02516013113.pdf"></self-uri>
<abstract>
<p>K<sup>+</sup>-dependent Na<sup>+</sup>/Ca<sup>2+</sup> exchangers belong to the solute carrier 24 (<italic>SLC24A1–5</italic>) gene family of membrane transporters. Five different gene products (NCKX1–5) have been identified in humans, which play key roles in biological processes including vision, olfaction, and skin pigmentation. NCKXs are bi-directional membrane transporters that transport 1 Ca<sup>2+</sup>+K<sup>+</sup> ions in exchange for 4 Na<sup>+</sup> ions. Recent studies have linked mutations in the <italic>SLC24A4</italic> (NCKX4) and <italic>SLC24A5</italic> (NCKX5) genes to amylogenesis imperfecta (AI) and non-syndromic oculocutaneous albinism (OCA6), respectively. Here, we introduced mutations found in patients with AI and OCA6 into human <italic>SLC24A4</italic> (NCKX4) cDNA leading to single residue substitutions in the mutant NCKX4 proteins. We measured NCKX-mediated Ca<sup>2+</sup> transport activity of WT and mutant NCKX4 proteins expressed in HEK293 cells. Three mutant NCKX4 cDNAs represent mutations found in the <italic>SCL24A4</italic> gene and three represent mutations found in the <italic>SCL24A5</italic> gene involving residues conserved between NCKX4 and NCKX5. Five mutant proteins had no observable NCKX activity, whereas one mutation resulted in a 78% reduction in transport activity. Total protein expression and trafficking to the plasma membrane (the latter with one exception) were not affected in the HEK293 cell expression system. We also analyzed two mutations in a <italic>Drosophila</italic> NCKX gene that have been reported to result in an increased susceptibility for seizures, and found that both resulted in mutant proteins with significantly reduced but observable NCKX activity. The data presented here support the genetic analyses that mutations in <italic>SLC24A4</italic> and <italic>SLC24A5</italic> are responsible for the phenotypic defects observed in human patients.</p>
</abstract>
<kwd-group>
<kwd>enzyme mutation</kwd>
<kwd>genetic disease</kwd>
<kwd>human genetics</kwd>
<kwd>membrane transport</kwd>
<kwd>sodium-calcium exchange</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>Canadian Institutes of Health Research
<named-content content-type="funder-id">http://dx.doi.org/10.13039/501100000024</named-content></funding-source>
<award-id>MOP-81327</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>